Discovery of novel cinnamic acid derivatives with anti-Helicobacter pylori mechanism.
Results suggested that compound 23 was a viable lead candidate for the treatment of Hp infection, and could cause severe cellular damage, disrupt biofilms, and inhibit urease, thereby blocking ammonia cloud formation.